Why the study?
CTO-PCI has been associated with improved clinical outcomes in observational studies but not in RCTs, leaving its impact inconclusive.
Does CTO-PCI improve clinical outcomes in patients with chronic total occlusion?
Does CTO-PCI improve clinical outcomes in patients with chronic total occlusion?
Answers are grounded in this paper and cite their sources.
Observational data suggests clinical benefit from CTO-PCI, but this is not supported by current RCTs, indicating a need for larger randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Simsek et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: